TD Cowen Remains a Hold on Option Care Health (OPCH)
In a report released today, Charles Rhyee from TD Cowen maintained a Hold rating on Option Care Health, with a price target of $37.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Rhyee is a 3-star analyst with an average return of 2.6% and a 49.39% success rate. Rhyee covers the Healthcare sector, focusing on stocks such as Cardinal Health, Cigna, and Option Care Health.
In addition to TD Cowen, Option Care Health also received a Hold from TipRanks – Anthropic’s Anthropic Medical – Care Facilities in a report issued today. However, on the same day, Deutsche Bank maintained a Buy rating on Option Care Health (NASDAQ: OPCH).
Based on Option Care Health’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.47 billion and a net profit of $58.5 million. In comparison, last year the company earned a revenue of $1.35 billion and had a net profit of $60.13 million
Read More on OPCH:
Disclaimer & DisclosureReport an Issue
- Option Care Health price target raised to $38 from $36 at Deutsche Bank
- Buy Rating Maintained as Stelara Headwind Fades and Core Profitability Remains Stable
- Option Care Health reports Q4 adjusted EPS 46c, consensus 47c
- Option Care Health sees FY26 adjusted EPS $1.82-$1.92, consensus $1.87
- OPCH Upcoming Earnings Report: What to Expect?
